Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Aakash Desai1, Vivek Subbiah2,3,4

  • 1Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Cancer
|October 30, 2022
PubMed

Immunotherapy has changed the landscape of cancer treatment. However, the benefit of immunotherapy is seen only in some cases, with most patients experiencing cancer progression despite treatment with immunotherapy. To overcome this, combination immunotherapy treatments are being studied. Herein, we propose for a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer.

Related Concept Videos